DNA - Ginkgo Bioworks Holdings, Inc.
6.5
-0.340 -5.231%
Share volume: 935,860
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$6.84
-0.34
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-25-2025 | 05-06-2025 | 11-06-2025 | 02-26-2026 | |
| Total revenue | 43.847 M | 48.318 M | 38.837 M | 33.396 M | |
| Cost of revenue | 9.622 M | 19.270 M | 12.802 M | -8.505 M | |
| Gross profit | 34.225 M | 29.048 M | 26.035 M | 41.901 M | |
| -15.13% | -10.37% | 60.94% | |||
| Operating expenses | 133.674 M | 119.966 M | 114.307 M | 96.141 M | |
| Selling general and admin | 57.297 M | 49.043 M | 44.954 M | 46.014 M | |
| Research and development | 76.377 M | 70.923 M | 69.353 M | 50.127 M | |
| Total expenses | 137.831 M | 125.239 M | 116.052 M | 96.847 M | |
| -9.14% | -7.34% | -16.55% | |||
| Operating income | -103.606 M | -88.968 M | -90.017 M | -65.937 M | |
| Ebit | -102.557 M | -93.257 M | -90.180 M | -65.116 M | |
| Pretax income | -107.859 M | -90.869 M | -80.754 M | -81.394 M | |
| -15.75% | -11.13% | 0.79% | |||
| Income tax | -325.000 K | 88.000 K | 1.000 K | -643.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -107.534 M | -90.957 M | -80.755 M | -80.751 M | |
| 15.42% | 11.22% | 0.00% |